← Data Explorer · All industries

Pharmaceutical preparations (SIC 2834)

Major group 28: Chemicals and allied products

Part of 283 Drugs

Companies with SIC industry code 2834. Companies with no code (SIC 0) and shell companies (SIC 9995) are left out.

As of2020 Q4
Data cover 2000 Q4 – 2020 Q4, quarterly.

The tiles, heatmap and tables below use the industry’s S&P 500 companies.

Companies in 2020 Q4 8
Average profit weight between them 0.52

Average profit weight in the industry over time

The mean profit weight over every ordered pair of the industry’s companies, each quarter: S&P 500 companies (solid) and all companies (faded). Click a quarter to show it.

    Computed from the current data release, using every firm in the sample. Published papers used earlier releases and samples, so their figures differ slightly.

    Show the numbers

    Profit weights between the 8 largest companies, 2020 Q4

    Each cell is the profit weight of the row company’s shareholders on the column company (darker: higher). Companies are ordered so that tightly linked groups form blocks. Largest means most reported owners. Click a cell to compare the two companies.

    Investors who drive it, 2020 Q4

    The investors that contribute most to the industry’s average profit weight: roughly, those holding sizeable stakes in many of its companies at once. Investor types are inferred from the forms each investor files with the SEC and are under review. Anyone filing Forms 3/4/5 counts as an insider unless they also file 13F, in which case they count as an asset manager (such as Carl Icahn).

    • Big Three
    • Asset manager
    • Non-financial blockholder
    • Activist
    • Insider
    #InvestorTypeCompanies held hereShare of the averageSEC CIKReport
    1 Vanguard Group Inc Big Three 832% 102909
    2 BlackRock Inc. Big Three 829% 1364742
    3 State Street Corp Big Three 88% 93751
    4 Capital International Inc /Ca/*Capital International Sarl*Capital International LTD /Ca/*Capital Research Global Investors*Capital World Investors*Capital International Investors*Capital Bank & Trust Co Asset manager 77% 732812
    5 Wellington Management Group LLP Asset manager 75% 902219
    6 FMR Llc*Fil LTD Asset manager 84% 315066
    7 Price T Rowe Associates Inc /MD/ Asset manager 74% 80255
    8 Geode Capital Management, LLC Asset manager 81% 1214717
    9 JPMorgan Chase & Co Asset manager 80.8% 19617
    10 Royce & Associates LP Asset manager 80.8% 38777
    11 Morgan Stanley Asset manager 80.6% 895421
    12 Northern Trust Corp Asset manager 80.6% 73124
    13 Alliancebernstein L.P. Asset manager 70.6% 1109448
    14 Bank of America Corp /DE/ Asset manager 80.5% 70858
    15 Janus Henderson Group PLC Asset manager 70.5% 1274173
    16 Norges Bank Asset manager 70.4% 1374170
    17 Nuveen Asset Management, LLC Asset manager 80.4% 1521019
    18 State Farm Mutual Automobile Insurance Co Asset manager 30.4% 315032
    19 Bank of New York Mellon Corp Asset manager 80.4% 1629943
    20 UBS Asset Management Americas Inc*Ubs Group AG Asset manager 80.3% 1610520
    21 Invesco LTD. Asset manager 70.2% 914208
    22 Legal & General Group PLC Asset manager 80.2% 764068
    23 United Capital Financial Advisers, LLC Asset manager 80.2% 886982
    24 California Public Employees Retirement System Asset manager 80.2% 919079
    25 Veritas Asset Management LLP Asset manager 30.1% 1541448

    The companies, 2020 Q4

    CompanyReported ownersReported ownershipSEC CIKReport
    Lilly Eli & Co SIC 2834 · S&P 500 175782.39%59478
    Zoetis Inc SIC 2834 · S&P 500 134591.02%1555280
    Viatris Inc SIC 2834 · S&P 500 115777.03%1792044
    Baxter International Inc SIC 2834 · S&P 500 106188.58%10456
    Vertex Pharmaceuticals Inc SIC 2834 · S&P 500 91491.99%875320
    Regeneron Pharmaceuticals Inc SIC 2834 · S&P 500 · dual class 84586.98%872589
    Catalent Inc SIC 2834 · S&P 500 518105.5%1596783
    Tilray Inc SIC 2834 · S&P 500 · dual class 20835.48%1731348

    Something look wrong? Report a problem with this page.

    These pages are for looking up individual companies and investors. Please don’t copy them with automated tools. If you need the full data, request a download: it is free of charge for academic research.